Skip to content

Observational Study on the Genomic Profile and Targeted Therapy in Parathyroid Carcinoma (Database Research Utilizing the Center for Cancer Genomics and Advanced Therapeutics (C-CAT))

Observational Study on the Genomic Profile and Targeted Therapy in Parathyroid Carcinoma (Database Research Utilizing the Center for Cancer Genomics and Advanced Therapeutics (C-CAT)) - Therapeutic target gene for parathyroid cancer (C-CAT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000058250
Enrollment
22
Registered
2025-06-27
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parathyroid carcinoma

Interventions

None listed

Sponsors

Shimane University
Lead Sponsor
National Cancer Center Japan Center for Cancer Genomic and Advanced Therapeutics
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Parathyroid carsinoma cases registered in the C-CAT database 2) Cases from 2019, when data collection began, to December 2024

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Genomic profiles of parathyroid cancer cases, frequency of mutations that could be therapeutic targets, and the proportion of cases for which treatment based on genomic profiles was actually recommended

Countries

Japan

Contacts

Public ContactMasakazu Notsu

Shimane University Faculty of Medicine Internal Medicine 1

mnotsu25@med.shimane-u.ac.jp+81-853-20-2183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026